Increased Circulating Exosomal miRNA-223 Is Associated with Acute Ischemic Stroke

Area of Science:

• Biochemistry
• Molecular Biology
• Neurology

Background:

• Exosomal microRNAs (miRNAs) are emerging biomarkers for various diseases, including vascular conditions.
• Specific exosomal miRNA expression patterns in acute ischemic stroke patients remain largely uncharacterized.

Purpose of the Study:

• To investigate circulating exosomal miRNAs as potential diagnostic biomarkers for acute ischemic stroke.
• To explore the clinical applicability of exosomal miRNAs in stroke diagnosis and outcome prediction.

Main Methods:

• Blood samples from 50 acute ischemic stroke patients were analyzed within 72 hours of symptom onset.
• Circulating exosomes were isolated, characterized via transmission electron microscopy, and confirmed using exosomal protein markers (CD9, CD63, Tsg101).
• Exosomal miRNA-223 (miR-223) levels were quantified using RT-PCR, and correlations with NIHSS scores and outcomes were assessed.

Main Results:

• Isolated exosomes measured 30-100 nm in size and expressed characteristic protein markers.
• Exosomal miR-223 was significantly upregulated in acute ischemic stroke patients compared to controls (p < 0.001).
• Exosomal miR-223 levels positively correlated with National Institutes of Health Stroke Scale (NIHSS) scores (r = 0.31, p = 0.03) and were higher in patients with poor short-term outcomes.

Conclusions:

• Increased exosomal miR-223 is associated with the occurrence, severity, and short-term outcomes of acute ischemic stroke.
• Circulating exosomal miR-223 shows potential as a novel biomarker for diagnosing acute ischemic stroke.
• Further large-scale studies are warranted to validate the clinical utility of exosomal miR-223 in ischemic stroke diagnosis.